Within the Council’s purview are (1) the benefits and risks of drug products, (2) evidence-based use of medicines, (3) the application of drug information in practice, and (4) related matters.
2022-2023 Term
| Name | Position | State |
| Kelly Bobo | Chair | Tennessee |
| Russel Roberts | Vice Chair | Massachusetts |
| Scott Bolesta | Member | Pennsylvania |
| Rachel Bubik | Member | Minnesota |
| Rachel Chandra | Member | Ohio |
| Jerika Lam | Member | California |
| Zahra Nasrazadani | Member | Kansas |
| Kristy Nguyen | Member | Oregon |
| David Silva | Member | Connecticut |
| Thomas Szymanski | Member | West Virginia |
| Kate Ward | Member | Nevada |
| Erica Um | Student | Missouri |
| Pam Phelps | Board Liaison | Minnesota |
| Vicki Basalyga | Secretary | Maryland |
